1. Home
  2. SIFY vs KALV Comparison

SIFY vs KALV Comparison

Compare SIFY & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sify Technologies Limited

SIFY

Sify Technologies Limited

HOLD

Current Price

$16.75

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIFY
KALV
Founded
1995
N/A
Country
India
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
SIFY
KALV
Price
$16.75
$26.72
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.60
AVG Volume (30 Days)
63.8K
4.4M
Earning Date
04-13-2026
07-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$50,000,000.00
Revenue This Year
N/A
$185.42
Revenue Next Year
$14.34
$59.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
495.66
52 Week Low
$4.15
$9.83
52 Week High
$17.85
$26.85

Technical Indicators

Market Signals
Indicator
SIFY
KALV
Relative Strength Index (RSI) 66.66 75.21
Support Level $10.74 $14.66
Resistance Level $16.95 N/A
Average True Range (ATR) 0.77 0.44
MACD 0.16 0.35
Stochastic Oscillator 76.25 98.35

Price Performance

Historical Comparison
SIFY
KALV

About SIFY Sify Technologies Limited

Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: